Christopher M. Gomez

Christopher Gomez practices at The University of Chicago Medical Center in Chicago, Illinois.

Christopher Gomez's NPI, 1184658478, was assigned on July 10, 2006. Christopher Gomez graduated from University of Chicago, Pritzker School of Medicine in 1983. Christopher Gomez holds Illinois license 036070622.

Christopher Gomez's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Christopher Gomez's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Christopher Gomez is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Christopher Gomez to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Gomez practices. Vendor and product names are available with a free account.

Neurology is Christopher Gomez's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Christopher Gomez is licensed in Illinois.

CMS data shows 172 Medicare services from Christopher Gomez across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $14,113 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Christopher Gomez in 2024. The largest group is 65 to 74, with 40 patients. 68% of them have high blood pressure, and 64% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Gomez's median patient age at 64, with 49% women.

In 2024, Christopher Gomez wrote 323 Medicare Part D claims for 60 patients. 85% of them were for generic drugs. CMS names the drug for 295 of them, across 10 drugs with 11 or more claims each, at $1,508,622 in total drug cost. In 2023, CMS named 218 claims across 8 drugs.

Christopher Gomez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Gomez as offering telehealth.

Dmand AI links 75 papers to Christopher Gomez, published from 2011 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Spinocerebellar Ataxias, Ataxia and Cerebellar Ataxia. Christopher Gomez has published most often in Cerebellum. Christopher Gomez's most frequent co-authors are Christopher S. Gomez, MD, Susan Lee Perlman, MD and Theresa A. Zesiewicz, MD.

Dmand AI links Christopher Gomez to 1 clinical trial. Conditions studied include Machado-Joseph Disease and Spinocerebellar Ataxias.

CMS Open Payments shows 20 general payments to Christopher Gomez from 3 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Biogen, Inc. paid the most, $36,709.

Christopher Gomez graduated from University of Chicago, Pritzker School of Medicine in 1983.